Stay updated on Guselkumab in Active PsA: Efficacy & Safety Clinical Trial

Sign up to get notified when there's something new on the Guselkumab in Active PsA: Efficacy & Safety Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Guselkumab in Active PsA: Efficacy & Safety Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-05-01T06:39:34.000Z thumbnail image
  2. Check
    15 days ago
    No Change Detected
  3. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant content removal regarding the study of guselkumab for Psoriatic Arthritis, including detailed descriptions of the study's purpose, methodology, and eligibility criteria. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.
    Difference
    8%
    Check dated 2025-04-16T21:59:14.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 4, 2025, while a date for March 25, 2025, has been removed.
    Difference
    0.1%
    Check dated 2025-04-09T16:59:09.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous date of February 4, 2025, and version 2.14.2.
    Difference
    0.1%
    Check dated 2025-04-02T01:29:37.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.4%
    Check dated 2025-02-25T00:25:11.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect new dates and locations, specifically changing from Poznań, Poland to Poznan, Poland, and updating the last update dates to early 2025. Additionally, there is a notice regarding heavy traffic affecting NLM-NCBI services.
    Difference
    0.7%
    Check dated 2025-02-10T18:21:11.000Z thumbnail image

Stay in the know with updates to Guselkumab in Active PsA: Efficacy & Safety Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Guselkumab in Active PsA: Efficacy & Safety Clinical Trial page.